扫码关注公众号           扫码咨询技术支持           扫码咨询技术服务
  
客服热线:400-901-9800  客服QQ:4009019800  技术答疑  技术支持  质量反馈  人才招聘  关于我们  联系我们
9月文献战报-Bioss抗体新增高分文献精彩呈现-北京博奥森生物技术有限公司
首页 > 新闻动态 > 正文
9月文献战报-Bioss抗体新增高分文献精彩呈现
发表者:北京博奥森生物      发表时间:2024-11-4


截止目前,引用Bioss产品发表的文献共31610篇总影响因子154046.6分,发表在Nature, Science, Cell以及Immunity等顶级期刊的文献共108篇,合作单位覆盖了清华、北大、复旦、华盛顿大学、麻省理工学院、东京大学以及纽约大学等国际知名研究机构上百所。

我们每月收集引用Bioss产品发表的文献。若您在当月已发表SCI文章,但未被我公司收集,请致电Bioss,我们将赠予现金鼓励,金额标准请参考“发文章 领奖金”活动页面。

近期收录2024年9月引用Bioss产品发表的文献共361篇(图一,绿色柱),文章影响因子(IF) 总和高达2253.2,其中,10分以上文献52篇(图二)。


图一


图二


本文主要分享引用Bioss 产品发表文章至Cancer Cell, Cell, Immunity, Nature Microbiology等期刊的 9篇 IF>15的文献摘要,让我们一起欣赏吧。


Cancer Cell [IF=48.8]

文献引用产品

S0134 | Alcian Blue Stain Kit (pH 2.5) | Other

作者单位:中山大学附属第一医院

摘要:Microsatellite stable (MSS) colorectal cancers (CRCs) are often resistant to anti-programmed death-1 (PD-1) therapy. Here, we show that a CRC pathogen, Fusobacterium nucleatum (Fn), paradoxically sensitizes MSS CRC to anti-PD-1. Fecal microbiota transplantation (FMT) from patients with Fn-high MSS CRC to germ-free mice bearing MSS CRC confers sensitivity to anti-PD-1 compared to FMT from Fn-low counterparts. Single Fn administration also potentiates anti-PD-1 efficacy in murine allografts and CD34+-humanized mice bearing MSS CRC. Mechanistically, we demonstrate that intratumoral Fn generates abundant butyric acid, which inhibits histone deacetylase (HDAC) 3/8in CD8+ T cells, inducing Tbx21 promoter H3K27 acetylation and expression. TBX21 transcriptionally represses PD-1, alleviating CD8+ T cell exhaustion and promoting effector function. Supporting this notion, knockout of a butyric acid-producing gene in Fn abolishes its anti-PD-1 boosting effect. In patients with MSS CRC, high intratumoral Fn predicts favorable response to anti-PD-1 therapy, indicating Fn as a potential biomarker of immunotherapy response in MSS CRC.


CELL [IF=45.5]

文献引用产品:

bs-2177R | Glypican 6 Rabbit pAb |IF

bs-11832R | Cux2 Rabbit pAb | IF

作者单位:美国加州大学

摘要:The development of successful therapeutics for dementias requires an understanding of their shared and distinct molecular features in the human brain. We performed single-nuclear RNA-seq and ATAC-seq in Alzheimer’s disease (AD), frontotemporal dementia (FTD), and progressive supranuclear palsy (PSP), analyzing 41 participants and ∼1 million cells (RNA + ATAC) from three brain regions varying in vulnerability and pathological burden. We identify 32 shared, disease-associated cell types and 14 that are disease specific. Disease-specific cell states represent glial-immune mechanisms and selective neuronal vulnerability impacting layer 5 intratelencephalic neurons in AD, layer 2/3 intratelencephalic neurons in FTD, and layer 5/6 near-projection neurons in PSP. We identify disease-associated gene regulatory networks and cells impacted by causal genetic risk, which differ by disorder. These data illustrate the heterogeneous spectrum of glial and neuronal compositional and gene expression alterations in different dementias and identify therapeutic targets by revealing shared and disease-specific cell states.


CELL [IF=45.5]

文献引用产品:

bs-1012R | BMP2 Rabbit pAb | WB, IHC

bs-5180R | AXL Rabbit pAb | WB, IHC

bsm-52179R | phospho-Nrf2 (Ser40) Recombinant Rabbit mAb | IHC

bs-8687R | p53 (FL-393) Rabbit pAb | WB

bs-1990R | MITF Rabbit pAb | IHC

作者单位:约翰霍普金斯大学

摘要:There is documented sex disparity in cutaneous melanoma incidence and mortality, increasing disproportionately with age and in the male sex. However, the underlying mechanisms remain unclear. While biological sex differences and inherent immune response variability have been assessed in tumor cells, the role of the tumor-surrounding microenvironment, contextually in aging, has been overlooked. Here, we show that skin fibroblasts undergo age-mediated, sex-dependent changes in their proliferation, senescence, ROS levels, and stress response. We find that aged male fibroblasts selectively drive an invasive, therapy-resistant phenotype in melanoma cells and promote metastasis in aged male mice by increasing AXL expression. Intrinsic aging in male fibroblasts mediated by EZH2 decline increases BMP2 secretion, which in turn drives the slower-cycling, highly invasive, and therapy-resistant melanoma cell phenotype, characteristic of the aged male TME. Inhibition of BMP2 activity blocks the emergence of invasive phenotypes and sensitizes melanoma cells to BRAF/MEK inhibition.


Immunity [IF=25.5]

文献引用产品:

bs-15186R-A647 | C4a+C4b Rabbit pAb | WB, IF

bs-10750R-A647 | C1QA Rabbit pAb | WB, IF (产品已升级为货号bs-11336R)

bs-10750R-A488 | C1QA Rabbit pAb | WB, IF (产品已升级为货号bs-11336R)

bs-0367G-A647 | Complement C3 Goat pAb | WB, IF

bs-7527R | FAIM3 Rabbit pAb | WB, IF

作者单位:德国慕尼黑大学医院

摘要:Venous thromboembolism (VTE) is a common, deadly disease with an increasing incidence despite preventive efforts. Clinical observations have associated elevated antibody concentrations or antibody-based therapies with thrombotic events. However, how antibodies contribute to thrombosis is unknown. Here, we show that reduced blood flow enabled immunoglobulin M (IgM) to bind to FcμR and the polymeric immunoglobulin receptor (pIgR), initiating endothelial activation and platelet recruitment. Subsequently, the procoagulant surface of activated platelets accommodated antigen- and FcγR-independent IgG deposition. This leads to classical complement activation, setting in motion a prothrombotic vicious circle. Key elements of this mechanism were present in humans in the setting of venous stasis as well as in the dysregulated immunothrombosis of COVID-19. This antibody-driven thrombosis can be prevented by pharmacologically targeting complement. Hence, our results uncover antibodies as previously unrecognized central regulators of thrombosis. These findings carry relevance for therapeutic application of antibodies and open innovative avenues to target thrombosis without compromising hemostasis.


Nature Microbiology [IF=20.5]

文献引用产品:

bs-0403R | Rabbit Anti-MG IgG H&L | WB

作者单位:英国斯特拉斯克莱德大学

摘要:Parasitic nematodes have an intimate, chronic and lifelong exposure to vertebrate tissues. Here we mined 41 published parasitic nematode transcriptomes from vertebrate hosts and identified 91 RNA viruses across 13 virus orders from 24 families in ~70% (28 out of 41) of parasitic nematode species, which include only 5 previously reported viruses. We observe widespread distribution of virus–nematode associations across multiple continents, suggesting an ancestral acquisition event and host–virus co-evolution. Characterization of viruses of Brugia malayi (BMRV1) and Onchocerca volvulus (OVRV1) shows that these viruses are abundant in reproductive tissues of adult parasites. Importantly, the presence of BMRV1 RNA in B. malayi parasites mounts an RNA interference response against BMRV1 suggesting active viral replication. Finally, BMRV1 and OVRV1 were found to elicit antibody responses in serum samples from infected jirds and infected or exposed humans, indicating direct exposure to the immune system.


Nature Microbilogy [IF=20.5]

文献引用产品:

bs-0812R | IL-1 Beta Rabbit pAb | IHC

作者单位:香港理工大学

摘要:Joint pain and osteoarthritis can occur as coronavirus disease 2019 (COVID-19) sequelae after infection. However, little is known about the damage to articular cartilage. Here we illustrate knee joint damage after wild-type, Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vivo. Rapid joint injury with cystic lesions at the osteochondral junction was observed in two patients with post-COVID osteoarthritis and recapitulated in a golden Syrian hamster model. SARS-CoV-2-activated endothelin-1 signalling increased vascular permeability and caused viral spike proteins leakage into the subchondral bone. Osteoclast activation, chondrocyte dropout and cyst formation were confirmed histologically. The US Food and Drug Administration-approved endothelin receptor antagonist, macitentan, mitigated cystic lesions and preserved chondrocyte number in the acute phase of viral infection in hamsters. Delayed macitentan treatment at post-acute infection phase alleviated chondrocyte senescence and restored subchondral bone loss. It is worth noting that it could also attenuate viral spike-induced joint pain. Our work suggests endothelin receptor blockade as a novel therapeutic strategy for post-COVID arthritis.


Advanced Functional Materials [IF=19.0]

文献引用产品:

bs-4727R | MRC1 Rabbit pAb | FC

作者单位:药物化学生物学国家重点实验室

摘要:Modulating inflammation is crucial for repairing vascular injury. Phagocytosis of apoptotic cells represents an effective mechanism for attenuating inflammation and improving regeneration during natural healing. However, strategies for repairing vascular injuries using biomaterials derived from apoptotic cells are still undeveloped. Herein, apoptotic body-mimetic nanovesicles (ApoNVs) derived from rat adipose-derived mesenchymal stem cells (rASCs) are prepared using a one-step extrusion method. ApoNVs inherit the unique anti-inflammatory and pro-regenerative properties of the parental apoptotic rASCs, as evidenced by enhanced M2 polarization of macrophages and promoted endothelial cell proliferation and migration following treatment with ApoNVs. Moreover, ApoNVs enhance the contractile phenotype of vascular smooth muscle cells through the mediation of ApoNVs-induced repolarized macrophages. After engineering ApoNVs with P-selectin binding peptide (ApoNVs-PBP), their ability to target injured artery increased nearly sevenfold compared to unmodified ApoNVs. In a rat wire-mediated femoral artery injury model, ApoNVs-PBP effectively suppress inflammation and significantly reduce blood flow velocity and neointimal hyperplasia at the injury site. ApoNVs exhibit similar therapeutic effects, though to a lesser extent. This study provides strong evidence validating the targeted delivery of ApoNVs as an innovative approach for repairing vascular injury and highlights their potential in treating other inflammatory diseases.


Advanced Fiber Materials [IF=17.2]

文献引用产品:

bs-1134R | RUNX2 Rabbit pAb | IHC

bs-4917R | Osteocalcin Rabbit pAb | IHC

作者单位:青岛大学附属医院

摘要:The development of biomimetic scaffolds that can promote osteogenic induction and vascularization is of great importance for the repair of large bone defects. In the present study, inorganic bioactive glass (BG) and organic polycaprolactone (PCL) are effectively combined by electrospinning and electrospray techniques to construct three-dimensional (3D) BG/PCL microfibrous spheres for the repair of bulk bone defects. The hybrid fibers, as well as the as-obtained 3D structure, can mimic the composition and architecture of native bone tissues. Furthermore, the BG/PCL microfibrous spheres show excellent biocompatibility and provide sufficient space and attachment sites for cell growth. The osteogenic differentiation of bone mesenchymal stem cells is also effectively facilitated when cultured on such hybrid microfibrous spheres. In vivo investigation utilizing rat femoral condyle bone defect models demonstrates that the BG/PCL microfibrous spheres loaded with bone mesenchymal stem cells can induce angiogenesis and promote the upregulation of bone-related protein expression, thus effectively facilitating bone regeneration at the defect site. The collective findings indicate that such BG/PCL hybrid microfibrous spheres have the potential to be effective carriers of stem cells. The microfibrous spheres loaded with stem cells have promising potential to be utilized as implantable biomaterials for the repair of bone defects.


ACS Nano [IF=15.8]

文献引用产品:

bs-5913R-FITC | Calreticulin Rabbit pAb, FITC conjugated | IF, FC

bs-5913R-BF488 | Calreticulin Rabbit pAb, BF488 conjugated | IF, FC
作者单位:中国科学院上海药物研究所

摘要:The refractory luminal androgen receptor (LAR) subtype of triple-negative breast cancer (TNBC) patients is challenged by significant resistance to neoadjuvant chemotherapy and increased immunosuppression. Regarding the distinct upregulation of glutathione (GSH) and glutathione peroxidase 4 (GPX4) in LAR TNBC tumors, we herein designed a GSH-depleting phospholipid derivative (BPP) and propose a BPP-based nanotherapeutics of RSL-3 (GDNS), aiming to deplete intracellular GSH and repress GPX4 activity, thereby potentiating ferroptosis for treating LAR-subtype TNBC. GDNS treatment drastically downregulated the expression of GSH and GPX4, resulting in a 33.88-fold enhancement of lipid peroxidation and significant relief of immunosuppression in the 4T1 TNBC model. Moreover, GDNS and its combination with antibody against programed cell death protein 1 (antiPD-1) retarded tumor growth and produced 2.83-fold prolongation of survival in the LAR-positive TNBC model. Therefore, the GSH-disrupting GDNS represents an encouraging strategy to potentiate ferroptosis for treating refractory LAR-subtype TNBC.


版权所有 2004-2026 www.bioss.com.cn 北京博奥森生物技术有限公司
通过国际质量管理体系ISO 9001:2015 GB/T 19001-2016    证书编号: 00124Q34771R2M/1100
通过国际医疗器械-质量管理体系ISO 13485:2016 GB/T 42061-2022    证书编号: CQC24QY10047R0M/1100
京ICP备05066980号-1         京公网安备110107000727号